1Griffith TS, Anderson RD, Davidson BL, et al. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol,2000, 165 (5) :2886-2894.
2Spierings DC, de Vries EG, Vellenga E, et al. Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem,2004, 52(6) :821-831.
3Kischkel FC, Lawrence DA, Chuntharapai A, et al. Apo2L/TRAILdependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 2000, 12 ( 6 ) :611 - 620.
4Shivapurkar N, Toyooka S, Toyooka KO, et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer, 2004, 109(5) :786-792.
5Miyashita T, Kawakami A, Nakashima T, et al. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor- related apoptosis- inducing ligand (TRAIL) - mediated apoptosis of fibroblast-like synovial cells. Clin Exp Immunol, 2004, 137 ( 2 ):430-436.
6Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res. 2000, 256( 1 ) :58-66.
7Zhang HG, Wang J, Yang X, et al. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene, 2004, 23 ( 11 ) :2009-2015.
8Nakshatri H, Rice SE, Bhat- Nakshatri P. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factorrelated apoptosis-inducing ligand through sustained activation of cJun N-terminal kinase. Oncogene, 2004, 23(44) :7330-7344.
9Lancaster JM, Sayer R, Blanchette C, et al. High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival. Clin Cancer Res, 2003, 9(2) :762-766.
